Although Stelara and Entyvio demonstrated similar cardiovascular safety profiles among older patients with inflammatory bowel ...

SAN FRANCISCO -- Research presented at the annual Crohn's and Colitis Congress included studies comparing the effectiveness ...

Persistent care barriers may lead patients with inflammatory bowel disease (IBD) to ration medication or skip doses. The ...

AbbVie’s Skyrizi has been approved by the FDA as a treatment for ulcerative colitis, making it the first ... and Takeda Pharma’s α4β7 inhibitor Entyvio (vedolizumab), both of which are ...

Eli Lilly has claimed FDA approval for its IL-23 inhibitor Omvoh as a treatment ... Entyvio (vedolizumab). Stelara was the first IL-23-targeted drug to reach the market for IBD and reigned supreme ...

For older adults with inflammatory bowel disease (IBD), there was no significant difference in the risk of major ...

An antibiotic used to treat infective diarrhea could be an effective drug for a type of inflammatory bowel disease, a new ...

Despite advances in treatment for inflammatory bowel disease, more than 55% of patients report medication delays, mostly due ...

An antibiotic used to treat infective diarrhoea could be an effective drug for a type of inflammatory bowel disease, a new study has found.

Portfolio Receipts of $742 million in Q4 2024 and $2,801 million for FY 2024Royalty Receipts growth of 12% in Q4 2024 and 13% for FY 2024 Net ...